secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001213900-26-005260
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech adds $295K to AlpineBrook secured note, principal now $26.1M
--------------------------------------------------------------------------

- Amendment to secured promissory note increases principal by $295,000 to $26,135,106.
- Interest on original $25,840,106 accrues from Jan 5, 2026; on additional $295,000 from Jan 12, 2026.
- Lender is AlpineBrook Capital GP I Limited; borrows are NKGen Biotech and NKGen Operating Biotech.
- All other terms of the January 5, 2026 note remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390026005260/0001213900-26-005260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390026005260/ea0272566-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-005260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer